Sunder Biomedical Tech Co

Sunder Biomedical Tech Co Equity

The The Equity of Sunder Biomedical Tech Co (4115.TWO) as of Oct 21, 2026 is 757.92 M TWD. In the previous year, The Equity was 777.43 M TWD — a change of -2.51% (lower).

Equity

757.92 MTWD

YoY

-2.51%

Last updated:

In 2025, Sunder Biomedical Tech Co's equity was 757.92 M TWD, a -2.51% increase from the 777.43 M TWD equity in the previous year.

The Sunder Biomedical Tech Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
755.45 M TWD
Jan 1, 2021
809.01 M TWD
Jan 1, 2022
790.45 M TWD
Jan 1, 2023
735.89 M TWD
Jan 1, 2024
777.43 M TWD
Jan 1, 2025
757.92 M TWD
The Sunder Biomedical Tech Co Equity history
YEAREquityYoY
757.92 MTWD-2.51%
777.43 MTWD+5.64%
735.89 MTWD-6.90%
790.45 MTWD-2.29%
809.01 MTWD+7.09%
755.45 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties. Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sunder Biomedical Tech Co's Equity

Sunder Biomedical Tech Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sunder Biomedical Tech Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sunder Biomedical Tech Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sunder Biomedical Tech Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sunder Biomedical Tech Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

The Equity of Sunder Biomedical Tech Co is 757.92 M TWD in 2025.

The Equity of Sunder Biomedical Tech Co changed from 777.43 M TWD to 757.92 M TWD, representing a -2.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sunder Biomedical Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co